KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Other financing activities (2017 - 2025)

Cardlytics (CDLX) has disclosed Other financing activities for 9 consecutive years, with $122000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities rose 913.33% year-over-year to $122000.0, compared with a TTM value of $122000.0 through Dec 2025, up 22.0%, and an annual FY2025 reading of $122000.0, up 22.0% over the prior year.
  • Other financing activities was $122000.0 for Q4 2025 at Cardlytics, up from -$34000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $239000.0 in Q1 2024 and bottomed at -$124000.0 in Q2 2024.
  • Average Other financing activities over 5 years is $41857.1, with a median of $12500.0 recorded in 2021.
  • The sharpest move saw Other financing activities soared 1710.0% in 2022, then crashed 726.67% in 2024.
  • Year by year, Other financing activities stood at -$10000.0 in 2021, then grew by 30.0% to -$7000.0 in 2022, then plummeted by 114.29% to -$15000.0 in 2023, then changed by 0.0% to -$15000.0 in 2024, then skyrocketed by 913.33% to $122000.0 in 2025.
  • Business Quant data shows Other financing activities for CDLX at $122000.0 in Q4 2025, -$34000.0 in Q2 2025, and $34000.0 in Q1 2025.